Consistently, decreased expression of VMAT2 is sufficient to cause dopamine‐mediated toxicity and neurodegeneration of nigrostriatal neurons,85, 91 providing further mechanistic support for the association between diabetes and increased vulnerability to nigrostriatal neurodegeneration. Here, SLC18A2 is linked to diabetes mellitus.